منبع: PRNewsWire
خبرگزاری
سهام
اهمیت متوسط

Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology
Targets $36 Billion TAM in Early Cancer Detection and MRD. Company in active discussions with global diagnostic leaders to accelerate commercialization.
نمادهای مرتبط
1
V
VNRX
VNRX
منبع: PRNewsWire
مشاهده منبع